NBD AI Bulletin -- Sichuan Kelun Pharmaceutical Co., Ltd. (the Company, SZ 002422, closing price: 22.95 yuan) announced on November 18, 2020, that the Company received a notice from its controlling shareholder Mr. Liu Gexin over share release issue.
The announcement said on the evening of November 18, Liu Gexin released 7.88 million pledged shares originally pledged to Huatai Securities (Shanghai) Asset Management Co., Ltd., accounting for 2.08% of his holdings.
The 2020 semi-annual report shows that Sichuan Kelun Pharmaceutical Co. Ltd. mainly engages in pharmaceutical manufacturing, accounting for 97.43% of its revenue.
Sichuan Kelun Pharmaceutical Co. Ltd.'s chairman is Liu Gexin, male, 69 years old, Chinese national, no permanent residence abroad, master's degree, senior engineer. The Company's general manager is Liu Sichuan, male, 36 years old, Chinese national, no permanent residence abroad, master's degree.
Tips on "Stock Trends":
1. The number of shares held by northbound investors decreased by 4.5839 million in the past 30 days, representing 0.42% of the Company's circulating shares.
2. There was no institutional research on the Company in the past 30 days.
(By Tan Yuhan)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.